ACCURAY WKN: A0MKWM ISIN: US0043971052 Kürzel: XEJ Forum: Aktien Thema: Hauptdiskussion
1,775 EUR
+0,28 %+0,005
23. Dec, 13:57:27 Uhr,
L&S Exchange
Kommentare 259
Summer.76,
02.12.2022 17:37 Uhr
0
https://m.marketscreener.com/quote/stock/ACCURAY-INCORPORATED-42550/news/ACCURAY-INC-Costs-Associated-with-Exit-or-Disposal-Activities-Financial-Statements-and-Exhibits--42456755/
Summer.76,
02.12.2022 17:36 Uhr
0
Costs Associated with Exit or Disposal Activities, Financial Statements and Exhibits (form 8-K)
https://www.marketscreener.com/quote/stock/ACCURAY-INCORPORATED-42550/news/ACCURAY-INC-Costs-Associated-with-Exit-or-Disposal-Activities-Financial-Statements-and-Exhibits--42456755/
...informed affected employees of a cost saving initiative designed to reduce operating costs through the elimination of approximately 4.5 percent of its global workforce. The Company expects to substantially complete the cost saving initiative in the second quarter of fiscal 2023.
The Company estimates the total cost of this initiative to be approximately $2.0 million, which is expected to be recorded in the second quarter of fiscal 2023.
Summer.76,
28.11.2022 17:06 Uhr
0
https://finance.yahoo.com/news/accuray-receives-imv-award-best-131000336.html
MrTraxxas,
16.11.2022 14:25 Uhr
1
https://investors.accuray.com/news-releases/news-release-details/oscar-lambret-center-france-installs-second-accuray-radixactr
Summer.76,
02.11.2022 21:25 Uhr
0
https://www.nasdaq.com/articles/accuray-incorporated-q1-loss-increases-misses-estimates
Accuray Incorporated Q1 Loss increases, misses estimates
Summer.76,
02.11.2022 21:09 Uhr
0
Accuray Reports Fiscal 2023 First Quarter Financial Results
https://www.prnewswire.com/news-releases/accuray-reports-fiscal-2023-first-quarter-financial-results-301666588.html
Strong customer demand. Navigating FX and Supply Chain Challenges. Company reiterates full year guidance.
Summer.76,
01.11.2022 12:36 Uhr
0
Accuray Announces Tomo® C Registration Submission to China's National Medical Products Administration
https://www.prnewswire.com/news-releases/accuray-announces-tomo-c-registration-submission-to-chinas-national-medical-products-administration-301664095.html
Summer.76,
26.10.2022 13:59 Uhr
0
New Reimbursement Approved by the Japanese Ministry of Health, Labor and Welfare for the Accuray CyberKnife® System to Treat Trigeminal Neuralgia, a Condition Often Causing Severe Facial Pain
https://www.prnewswire.com/news-releases/new-reimbursement-approved-by-the-japanese-ministry-of-health-labor-and-welfare-for-the-accuray-cyberknife-system-to-treat-trigeminal-neuralgia-a-condition-often-causing-severe-facial-pain-301659442.html
MrTraxxas,
21.10.2022 18:25 Uhr
1
https://investors.accuray.com/news-releases/news-release-details/ge-healthcare-and-accuray-collaborate-expand-access-advance
MrTraxxas,
19.10.2022 15:06 Uhr
0
Prima
abeni,
19.10.2022 14:42 Uhr
0
https://www.stockilluminati.com/aray/news.php
abeni,
19.10.2022 14:41 Uhr
1
Sun Nuclear arbeitet mit Accuray zusammen, um neue Qualitätsmanagementlösungen für das Radixact-System mit Synchrony zu entwickeln
Summer.76,
13.10.2022 15:33 Uhr
1
Accuray and C-RAD Unveil Automated Breast Cancer Treatment Package for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting
https://www.prnewswire.com/news-releases/accuray-and-c-rad-unveil-automated-breast-cancer-treatment-package-for-the-radixact-system-at-american-society-for-radiation-oncology-astro-annual-meeting-301648231.html
...will showcase an important new option for improving the care of people diagnosed with breast cancer during the 2022 ASTRO (American Society for Radiation Oncology) Annual Meeting in San Antonio, Texas, October 23 – 26, 2022.
MrTraxxas,
13.10.2022 15:32 Uhr
1
https://investors.accuray.com/news-releases/news-release-details/accuray-and-c-rad-unveil-automated-breast-cancer-treatment
abeni,
11.10.2022 13:42 Uhr
1
In The Lancet Oncology veröffentlichte Daten weisen darauf hin, dass bei Männern mit Prostatakrebs, die mit der Accuray CyberKnife(R)-Plattform behandelt wurden, weniger Blasennebenwirkungen auftraten als bei Männern, die mit herkömmlichen Linearbeschleunigern behandelt wurden https://www.stocktitan.net/news/ARAY/data-published-in-the-lancet-oncology-indicate-men-with-prostate-sab8ayvqf5zx.html
abeni,
30.09.2022 13:43 Uhr
1
Accuray kündigt erste CyberKnife ® -Systeme in Afrika an, die eine neue Option und Hoffnung auf potenziell lebensrettende Strahlenbehandlungen für mehr Krebspatienten bieten
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | ATOS Hauptdiskussion | +2,27 % | |
2 | TILRAY INC. CL.2 DL-,0001 Hauptdiskussion | +8,02 % | |
3 | Cherry Hauptdiskussion | +15,48 % | |
4 | VALNEVA SE Hauptdiskussion | -2,54 % | |
5 | CYTOMX THERAPEUTICS INC. Hauptdiskussion | -0,19 % | |
6 | MANZ Hauptdiskussion | +7,88 % | |
7 | NVIDIA Hauptdiskussion | +1,98 % | |
8 | Dax Prognose | +0,03 % | |
9 | Palantir ohne Schnickschnack | +2,61 % | |
10 | DPCM Capital Hauptdiskussion | +16,18 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | ATOS Hauptdiskussion | +2,27 % | |
2 | TILRAY INC. CL.2 DL-,0001 Hauptdiskussion | +8,02 % | |
3 | Cherry Hauptdiskussion | +15,48 % | |
4 | VALNEVA SE Hauptdiskussion | -2,54 % | |
5 | CYTOMX THERAPEUTICS INC. Hauptdiskussion | -0,19 % | |
6 | MANZ Hauptdiskussion | +7,88 % | |
7 | NVIDIA Hauptdiskussion | +1,77 % | |
8 | Palantir ohne Schnickschnack | +1,69 % | |
9 | DPCM Capital Hauptdiskussion | +14,29 % | |
10 | BAYER Hauptdiskussion | -1,02 % | Alle Diskussionen |